Moneycontrol
HomeNewsBusinessStocksStocks in news: Tata Motors, Sun Pharma, BHEL, Aurobindo
Trending Topics

Stocks in news: Tata Motors, Sun Pharma, BHEL, Aurobindo

Tata Motors | Sun Pharma | BHEL | ONGC | Coal India | HPCL | BPCL | Hathway Cable | Unitech | Gitanjali Gems | Britannia | Punjab & Sind Bank | Andhra Bank | Dena Bank | Aurobindo Pharma | PC Jeweller | Ashoka Buildcon and Oil India are stocks, which are in the news today.

November 09, 2015 / 09:48 IST
Story continues below Advertisement

Here are stocks that are in news today:

Results today: BPCL, HPCL, Oil India, Havells India, Aditya Birla Nuvo, Allahabad Bank, Balkrishna Industries, Central Bank of India, NBCC, NHPC Limited, Page Industries, REC, Pfizer, Tata Power, UFO Moviez, Orchid Chemical, GSFC, Alok Industries, Alpa Lab, Ansal Housing, Ansal Properties, APL Apollo Tubes, Dwarikesh Sugar, Educomp Solutions, Fedders Lloyd, Genus Power, Graphite India, HMT, ITI, Kohinoor Foods, Lanco Infra, Linde India, Lloyd Electric & Engineering, LT Foods, Man Ind, Maxwell Industries, Oswal Chemicals, Suprajit Engineering, Take Solutions, State Trading Corporation, Timken India, VST Tillers Tractors, Vadilal Industries, WABCO India, Zodiac Clothing

Story continues below Advertisement

Tata Motors Q2-Consolidated net loss at Rs 430 crore versus profit of Rs 3,291 crore (YoY)-Consolidated total income at Rs 61,318 crore versus Rs 60,641 crore (YoY)-Consolidated EBITDA at Rs 6,881 crore versus Rs 9,569 crore (YoY)-Consolidated EBITDA margin at 11.2 percent versus 15.8 percent (YoY)-Consolidated forex loss at Rs 114 crore versus gain of Rs 26.5 crore (YoY)-Consolidated tax credit at Rs 703.6 crore versus tax expense of Rs 2,364 crore (YoY)-Consolidated one-time loss of Rs 2,493 crore due to explosion at Tianjin port-Standalone net loss at Rs 287.5 crore versus loss of Rs 1,846 crore (YoY)-Standalone total income Rs 10,501 crore versus Rs 8,752 crore (YoY)-Standalone EBITDA at Rs 612 crore versus loss of Rs 262 crore (YoY)-Standalone EBITDA margin at 5.8 percent versus -3 percent (YoY)-JLR Net loss at £92 million versus profit of £450 million (YoY)-JLR revenue at £4,831 million versus £4,808 million (YoY)-JLR EBITDA at £589 million versus £933 million (YoY)-JLR EBITDA margin at 12.2 percent versus 19.4 percent (YoY)

Sun Pharma Q2-Consolidated net profit at Rs 1,108.7 crore versus Rs 479 crore (QoQ)Alert: Sun Pharma had an exceptional loss of Rs 685.2 crore in Q1FY16-Consolidated net sales up 4.3 percent at Rs 6,803.3 crore versus Rs 6525.8 crore (QoQ)-Consolidated EBITDA up 15.6 percent at Rs 1,899 crore versus Rs 1,643 crore (QoQ)-Consolidated EBITDA margin at 27.9 percent versus 25.2 percent (QoQ)